The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome

Imbalanced gut microbiota (GM) and abnormal fecal bile acid (BA) are thought to be the key factors for diarrhea-predominant irritable bowel syndrome (IBS-D), but the underlying mechanism remains unclear. Herein, we explore the influence of the GM-BA-Takeda G-protein-coupled receptor 5 (TGR5) axis on IBS-D. Twenty-five IBS-D patients and fifteen healthy controls were recruited to perform BA-related metabolic and metagenomic analyses. Further, the microbiota-humanized IBS-D rat model was established by fecal microbial transplantation (FMT) to investigate the GM-BA-TGR5 axis effects on the colonic barrier and visceral hypersensitivity (VH) in IBS-D. Finally, we used chenodeoxycholic acid (CDCA), an important BA screened out by metabolome, to evaluate whether it affected diarrhea and VH via the TGR5 pathway. Clinical research showed that GM associated with bile salt hydrolase (BSH) activity such as Bacteroides ovatus was markedly reduced in the GM of IBS-D, accompanied by elevated total and primary BA levels. Moreover, we found that CDCA not only was increased as the most important primary BA in IBS-D patients but also could induce VH through upregulating TGR5 in the colon and ileum of normal rats. TGR5 inhibitor could reverse the phenotype, depression-like behaviors, pathological change, and level of fecal BSH in a microbiota-humanized IBS-D rat model. Our findings proved that human-associated FMT could successfully induce the IBS-D rat model, and the imbalanced GM-BA-TGR5 axis may promote colonic mucosal barrier dysfunction and enhance VH in IBS-D.

IMPORTANCE: Visceral hypersensitivity and intestinal mucosal barrier damage are important factors that cause abnormal brain-gut interaction in diarrhea-predominant irritable bowel syndrome (IBS-D). Recently, it was found that the imbalance of the gut microbiota-bile acid axis is closely related to them. Therefore, understanding the structure and function of the gut microbiota and bile acids and the underlying mechanisms by which they shape visceral hypersensitivity and mucosal barrier damage in IBS-D is critical. An examination of intestinal feces from IBS-D patients revealed that alterations in gut microbiota and bile acid metabolism underlie IBS-D and symptom onset. We also expanded beyond existing knowledge of well-studied gut microbiota and bile acid and found that Bacteroides ovatus and chenodeoxycholic acid may be potential bacteria and bile acid involved in the pathogenesis of IBS-D. Moreover, our data integration reveals the influence of the microbiota-bile acid-TGR5 axis on barrier function and visceral hypersensitivity.

Medienart:	E-Artikel

Erscheinungsjahr:	2024
Erschienen:	2024

Enthalten in:	Zur Gesamtaufnahme - volume:9
Enthalten in:	mSystems - 9(2024), 3 vom: 19. März, Seite e0129923

Sprache:	Englisch

Beteiligte Personen:	Zhan, Kai [VerfasserIn] Wu, Haomeng [VerfasserIn] Xu, Yongyin [VerfasserIn] Rao, Kehan [VerfasserIn] Zheng, Huan [VerfasserIn] Qin, Shumin [VerfasserIn] Yang, Yuanming [VerfasserIn] Jia, Rui [VerfasserIn] Chen, Weihuan [VerfasserIn] Huang, Shaogang [VerfasserIn]

Links:	Volltext

Themen:	0GEI24LG0J Bile Acids and Salts Bile acid Chenodeoxycholic Acid Diarrhea-predominant irritable bowel syndrome Gut microbiota Journal Article TGR5

Anmerkungen:	Date Completed 20.03.2024 Date Revised 21.03.2024 published: Print-Electronic Citation Status MEDLINE

doi:	10.1128/msystems.01299-23

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	NLM368194396